431 related articles for article (PubMed ID: 17674958)
21. The need for effective pancreatic cancer detection and management: a biomarker-based strategy.
Crawley AS; O'Kennedy RJ
Expert Rev Mol Diagn; 2015; 15(10):1339-53. PubMed ID: 26394703
[TBL] [Abstract][Full Text] [Related]
22. Genetic diagnosis of pancreatic cancer.
Mizumoto K; Tanaka M
J Hepatobiliary Pancreat Surg; 2002; 9(1):39-44. PubMed ID: 12021896
[TBL] [Abstract][Full Text] [Related]
23. Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?
Partensky C
Pancreas; 2013 Jul; 42(5):729-39. PubMed ID: 23648843
[TBL] [Abstract][Full Text] [Related]
24. Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer.
Funel N; Giovannetti E; Pollina LE; del Chiaro M; Mosca F; Boggi U; Campani D
Expert Rev Mol Diagn; 2011 Sep; 11(7):695-701. PubMed ID: 21902531
[TBL] [Abstract][Full Text] [Related]
25. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.
Singh P; Srinivasan R; Wig JD
Pancreas; 2011 Jul; 40(5):644-52. PubMed ID: 21673535
[TBL] [Abstract][Full Text] [Related]
26. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).
Carmicheal J; Patel A; Dalal V; Atri P; Dhaliwal AS; Wittel UA; Malafa MP; Talmon G; Swanson BJ; Singh S; Jain M; Kaur S; Batra SK
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188318. PubMed ID: 31676330
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
[TBL] [Abstract][Full Text] [Related]
28. [Tumour markers of pancreatic cancer--Part II (molecular markers of carcinogenesis and non-specific tumour markers)].
Groblewska M; Mroczko B; Karpiuk E; Szmitkowski M
Pol Arch Med Wewn; 2005 Nov; 114(5):1118-27. PubMed ID: 16789513
[No Abstract] [Full Text] [Related]
29. The molecular genetics of pancreatic ductal carcinoma.
Sohn TA
Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy.
Nakaizumi A; Uehara H; Takenaka A; Uedo N; Sakai N; Yano H; Ohigashi H; Ishikawa O; Ishiguro S; Sugano K; Tatsuta M
Hepatogastroenterology; 1999; 46(25):31-7. PubMed ID: 10228761
[TBL] [Abstract][Full Text] [Related]
31. Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of pancreatic cancer.
Visser IJ; Levink IJM; Peppelenbosch MP; Fuhler GM; Bruno MJ; Cahen DL
Pancreatology; 2022 Nov; 22(7):973-986. PubMed ID: 35864067
[TBL] [Abstract][Full Text] [Related]
32. Expression of cathepsin E in pancreas: a possible tumor marker for pancreas, a preliminary report.
Azuma T; Hirai M; Ito S; Yamamoto K; Taggart RT; Matsuba T; Yasukawa K; Uno K; Hayakumo T; Nakajima M
Int J Cancer; 1996 Aug; 67(4):492-7. PubMed ID: 8759606
[TBL] [Abstract][Full Text] [Related]
33. Molecular markers in pancreatic cancer diagnosis.
Herreros-Villanueva M; Gironella M; Castells A; Bujanda L
Clin Chim Acta; 2013 Mar; 418():22-9. PubMed ID: 23305796
[TBL] [Abstract][Full Text] [Related]
34. Detection and proteomic characterization of extracellular vesicles in human pancreatic juice.
Osteikoetxea X; Benke M; Rodriguez M; Pálóczi K; Sódar BW; Szvicsek Z; Szabó-Taylor K; Vukman KV; Kittel Á; Wiener Z; Vékey K; Harsányi L; Szűcs Á; Turiák L; Buzás EI
Biochem Biophys Res Commun; 2018 Apr; 499(1):37-43. PubMed ID: 29550476
[TBL] [Abstract][Full Text] [Related]
35. Elevated expression level of microRNA-196a is predictive of intestinal-type intraductal papillary mucinous neoplasm of the pancreas.
Aso T; Ohtsuka T; Tamura K; Ideno N; Kono H; Nagayoshi Y; Ohuchida K; Ueda J; Takahata S; Shindo K; Aishima S; Oda Y; Mizumoto K; Tanaka M
Pancreas; 2014 Apr; 43(3):361-6. PubMed ID: 24622064
[TBL] [Abstract][Full Text] [Related]
36. Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.
Makawita S; Smith C; Batruch I; Zheng Y; Rückert F; Grützmann R; Pilarsky C; Gallinger S; Diamandis EP
Mol Cell Proteomics; 2011 Oct; 10(10):M111.008599. PubMed ID: 21653254
[TBL] [Abstract][Full Text] [Related]
37. Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Yamada D; Fujii K; Ishikawa N; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Int J Cancer; 2006 Jan; 118(2):405-11. PubMed ID: 16052519
[TBL] [Abstract][Full Text] [Related]
38. Early detection of sporadic pancreatic cancer: summative review.
Chari ST; Kelly K; Hollingsworth MA; Thayer SP; Ahlquist DA; Andersen DK; Batra SK; Brentnall TA; Canto M; Cleeter DF; Firpo MA; Gambhir SS; Go VL; Hines OJ; Kenner BJ; Klimstra DS; Lerch MM; Levy MJ; Maitra A; Mulvihill SJ; Petersen GM; Rhim AD; Simeone DM; Srivastava S; Tanaka M; Vinik AI; Wong D
Pancreas; 2015 Jul; 44(5):693-712. PubMed ID: 25931254
[TBL] [Abstract][Full Text] [Related]
39. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.
Del Chiaro M; Verbeke CS; Kartalis N; Pozzi Mucelli R; Gustafsson P; Hansson J; Haas SL; Segersvärd R; Andren-Sandberg Å; Löhr JM
JAMA Surg; 2015 Jun; 150(6):512-8. PubMed ID: 25853369
[TBL] [Abstract][Full Text] [Related]
40. Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.
Jin K; Luo G; Xiao Z; Liu Z; Liu C; Ji S; Xu J; Liu L; Long J; Ni Q; Yu X
Drug Des Devel Ther; 2015; 9():1247-55. PubMed ID: 25750521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]